Colorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical Group
  • Home
  • Contact Us
  • About Us
  • In the News
  • Clinical Tools

Amyloidosis Staging

Cardiac

Marker/Thresholds:  

  • NT-proBNP > 332 ng/L
  • cTnT > 0.035 ng/mL

Stages:

  • I. no markers above cutoffs
  • II. one marker above cutoffs
  • IIIa. both markers above cutoffs and NT-proBNP < 8500 ng/L
  • IIIb. both markers above cutoffs and NT-proBNP 8500 ng/L or higher


Revised Mayo

Marker/Thresholds:

  • NT-proBNP > 1800 ng/L
  • cTnT >0.025 ng/mL
  • dFLC > 180 mg/L

Stages: 

  • I. 0 markers above cutoffs
  • II. 1 marker above cutoffs
  • III. 2 markers above cutoffs
  • IV. 3 markers above cutoffs


Renal

Marker/Thresholds:

  • eGFR < 50 mL/min/1.73m^2
  • Proteinuria > 5g/24h

Stages:

  • I. both eGFR above and proteinuria below cutoffs
  • II. either eGFR below or proteinuria above cutoffs
  • III. both eGFR below and proteinuria above cutoffs

Copyright © 2025 Colorado Blood Cancer Institute Medical Group - All Rights Reserved.


Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept